Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KYTX

Kyverna Therapeutics Inc

May 12 • 04:00PM ET

10.23

-0.11 -1.06 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CABA RNAC CRBU FATE SANA

| Held by: VTI VXF IBB SCHA DWAS SURI IWC AVSC PRFZ DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.66	Insider Own	38.00%	Shs Outstand	60.39M	Perf Week	11.07%
Market Cap	619.22M	Forward P/E	-	EPS next Y	-2.97	Insider Trans	1.07%	Shs Float	37.53M	Perf Month	7.80%
Enterprise Value	369.00M	PEG	-	EPS next Q	-0.70	Inst Own	42.51%	Short Float	13.75%	Perf Quarter	30.32%
Income	-161.31M	P/S	-	EPS this Y	19.92%	Inst Trans	21.40%	Short Ratio	6.09	Perf Half Y	55.47%
Sales	0.00M	P/B	2.66	EPS next Y	-1.77%	ROA	-53.64%	Short Interest	5.16M	Perf YTD	8.83%
Book/sh	3.85	P/C	2.22	EPS next 5Y	13.65%	ROE	-64.67%	52W High	13.67 -25.16%	Perf Year	362.90%
Cash/sh	4.61	P/FCF	-	EPS past 3/5Y	-75.86% -56.27%	ROIC	-62.68%	52W Low	2.06 396.60%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.26% 8.73%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-5.71%	Oper. Margin	-	ATR (14)	0.73	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.75	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	60.34	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.75	EPS Q/Q	7.59%	SMA20	8.41%	Beta	2.11	Target Price	29.40
Payout	-	Debt/Eq	0.12	Sales Q/Q	-	SMA50	14.39%	Rel Volume	0.72	Prev Close	10.34
Employees	130	LT Debt/Eq	0.11	Earnings	May 12 AMC	SMA200	41.60%	Avg Volume	847.07K	Price	10.23
IPO	Feb 08, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.20% -	Trades		Volume	616,824	Change	-1.06%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)